期刊文献+

HPLC测定清洁验证残留物非诺贝特的含量 被引量:3

Determination of Fenofibrate Residues in Cleaning Validation of Fenofibrate Sustained-release Tablets by HPLC
在线阅读 下载PDF
导出
摘要 目的:建立清洁验证中残留物非诺贝特含量测定的高效液相色谱法。方法:色谱柱为Agilent ZORBAX SB-C18(150 mm×4.6 mm,5μm),流动相为水(磷酸调节p H至2.5)-乙腈(30∶70),检测波长:286 nm,流速:1.0 m L/min,柱温:25℃,进样量:20μL。结果:非诺贝特在0.09-0.90μg/m L范围内线性关系良好,r2=0.999 4;回收率:99.69%,RSD=0.16%(n=9)。结论:该法操作简便、结果准确,可以用于清洁验证残留物非诺贝特的定量分析。 Objective:To establish a method for the content determination of fenofibrate residues in the cleaning validation of fenofibrate sustained-release tablets by HPLC. Methods: Separation was carried out using Agilent ZOR- BAX SB-C18 ( 150 mm× 4.6 ram, 5 μm) column with phosphoric acid solution (pH = 2.5 )-acetonitrile (30:70) as the mobile phase, the detection wavelength was at 286 nm, the flow was 1.0 mL/min and the column temperature was at 25 ℃ with sample size of 20 txL. Results: The linear range of fenofibrate concentration was from 0.09 to 0.90 μg/mL and the correlation coefficient was 0.999 4. The average recovery of samples was 99.69% and RSD was 0.16%(n = 9). Conclusion: This method is convenient and accurate without interference and is suitable for the quantitative determination of fenofibrate residues in the cleaning validation of fenofibrate sustained-release tablets.
出处 《中国执业药师》 CAS 2015年第8期28-31,共4页 China Licensed Pharmacist
关键词 高效液相色谱法 清洁验证 残留物 非诺贝特 HPLC Cleaning Validation Residue Fenofibrate
作者简介 洪丽萍,女,药师。研究方向:药物分析和标准研究。E—mail:hongliping@yangzijiang.com
  • 相关文献

参考文献1

二级参考文献22

  • 1全球药品研发进展(2006.7)[J].中国医药工业杂志,2007,38(1). 被引量:1
  • 2纳米技术用于给药系统研究进展不断[J].中国医药技术与市场,2007,7(4):61-61. 被引量:1
  • 3Keating GM,Croom KF.Fenofibrate:A review of its use in primary dyslipidaemia,the metabolic syndrome and type 2 diabetes mellitus[J].Drugs,2007,67(1):121-153.
  • 4Fournier Innovation et Synergie.Novel dosage form of fenofibrate[P].US:4895726,1990-01-23.
  • 5Guichard JP,Blouquin P,Qing Y.A new formulation of fenofibrate:Suprabioavailable tablets[J].Current Medical Research and Opinion,2000,16(2):134-138.
  • 6Shegokar R,Moller RE Nanocrystals:Industrially feasible multifunctional formulation technology for poorly soluble actives[J].Int J Pharm,2010,399(1-2):129-139.
  • 7Mochalin VN,Sagar A,Gour S,et al.Manufacturingnanosized fenofibrate by salt assisted milling[J].Pharm Res,2009,26(6):1365-1370.
  • 8Srinarong P,Faber JH,Visser MR,et al.Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants[J].Eur J Pharm Biopharm,2009,73(1):154-161.
  • 9Patel T,Pate LD,Patel T,et al.Enhancement of dissolution of Fenofibrate by solid dispersion technique[J].Int J Res Pharm Sci,2010,1(2):127-132.
  • 10He H,Yang R,Tang X.In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion[J].Drug Dev Ind Pharm,2010,36(6):681-687.

共引文献20

同被引文献39

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部